• IPA-3: A Translational Lens on Pak1 Signaling

  2026-08-18

  A mechanistic and strategic guide to using IPA-3 for Pak1 pathway interrogation, kinase assays, cell signaling, neuroinflammation, cancer biology, and evidence-based translational decisions.

• Gentamycin Sulfate: Workflows for Resistance Research

  2026-08-17

  Build reproducible assays for bacterial protein synthesis, ribosome function, and resistance phenotyping with a water-soluble aminoglycoside antibiotic. This guide shows how to use Gentamycin Sulfate as a mechanistic challenge, a comparator in Gram-negative models, and a stressor for resistance-selection workflows without treating its activity as a surrogate for newer antibiotics.

• LY364947: Designing Causal TGF-β Assays

  2026-08-17

  LY364947 is a TGF-β type I receptor kinase inhibitor for dissecting Smad signaling, EMT, and fibrosis models. This assay-centered guide connects receptor-level perturbation with recent evidence on Wnt/β-catenin and TGF-β crosstalk, emphasizing reproducible experimental decisions.

• TAK-715: A Practical p38 MAPK Inhibitor Workflow

  2026-08-16

  TAK-715 combines nanomolar p38α activity with a practical workflow for cytokine, stress-response, and rheumatoid arthritis research. This guide explains how to build cell-based assays, interpret phospho-signaling data, translate findings toward inflammation models, and troubleshoot selectivity, solubility, and timing problems.

• Clathrin-Mediated Entry of Type III Grass Carp Reovirus

  2026-08-15

  Wang et al. combined pharmacological inhibition, transmission electron microscopy, and real-time quantitative PCR to define how genotype III grass carp reovirus enters cultured fish cells. Their results identify a dynamin-dependent, clathrin-mediated and endosomal pH-dependent route, while the lack of inhibition by IPA-3 helps exclude Pak1-linked signaling under the tested conditions.

• Luminescent ATP Cell Viability Assay Kit I Guide

  2026-08-14

  This scenario-driven guide explains how Luminescent ATP Cell Viability Assay Kit I (SKU K2041) supports sensitive, rapid cell viability measurement, cytotoxicity assay design, and proliferation studies. It covers assay principles, protocol parameters, interpretation limits, and practical vendor-selection criteria for reliable luciferase luminescence detection.

• IPA-3: A Mechanistic Lens on Pak1 Signaling

  2026-08-14

  IPA-3 is a non-ATP-competitive Pak1 inhibitor that can do more than suppress kinase signaling. This article examines how its negative result in a grass carp reovirus entry study informs pathway localization, assay design, and responsible translation into cancer and neuroinflammation research.

• Losmapimod Workflows for p38 MAPK Research

  2026-08-13

  Losmapimod (GW856553X) provides a practical way to interrogate p38α/β signaling in inflammatory, endothelial, vascular, and airway models. This workflow-centered guide combines formulation guidance with a structure-informed strategy for distinguishing simple kinase inhibition from accelerated p38α dephosphorylation.

• SCUBE3 Antibody Targeting in Cancer Progression

  2026-08-13

  The reference study identifies secreted SCUBE3 as a convergent driver of oncogenic signaling, therapy resistance, and tumor immune suppression. Its neutralizing antibody approach provides a preclinical framework for blocking SCUBE3–receptor interactions while restoring immune visibility, with EGFR-directed tools such as Erlotinib offering complementary ways to interrogate pathway dependence.

• Clodronate Liposomes for Macrophage Depletion

  2026-08-12

  Clodronate Liposomes provide a practical way to test whether macrophages drive tumor growth, inflammation, or treatment resistance in vivo. This guide connects phagocytosis-mediated drug delivery with tissue-specific study design, controls, validation, and troubleshooting for translational immune research.

• Human SAN-Plexus Assembloids and Pacemaker Maturation

  2026-08-12

  This study develops human pluripotent stem cell-derived assembloids that combine sinoatrial node, cardiac ganglionated plexus, and atrial-like tissues to model neuro-cardiac control of pacemaker maturation. By pairing functional electrophysiology with human SAN spatial transcriptomics, the authors identify a prosaposin–GPR37 signaling axis that links cardiac neurons to pacemaker development and conduction.

• PF-573228 FAK Inhibitor Workflow for Mechanobiology

  2026-08-11

  Use PF-573228 to separate stiffness-driven adhesion signaling from downstream dentinogenesis, migration, and angiogenesis phenotypes. This practical workflow combines phospho-FAK validation, substrate-aware controls, and troubleshooting guidance for reproducible mechanobiology and cancer research.

• Sorafenib (BAY-43-9006) Research Workflows

  2026-08-11

  Build more informative oncology assays with Sorafenib by separating Raf/MEK/ERK signaling, receptor tyrosine kinase activity, angiogenesis, and cell-killing effects. An ATRX-stratified workflow extends this multikinase inhibitor from routine viability testing into mechanistic glioma and hepatocellular carcinoma model research.

• Anlotinib: Preclinical VEGFR2 Inhibition

  2026-08-10

  The reference study established anlotinib as a highly potent, orally active VEGFR2 inhibitor that suppresses tumor angiogenesis across biochemical, endothelial-cell, ex vivo, and xenograft models. Its central contribution was to connect strong VEGFR2 selectivity with functional inhibition of endothelial migration, tube formation, vascular outgrowth, and tumor-associated microvessels, while also clarifying the limits of direct tumor-cell inhibition.

• Thapsigargin B6614 for Reliable Cell Assays

  2026-08-09

  Learn how Thapsigargin (SKU B6614) can standardize SERCA inhibition across calcium imaging, apoptosis assays, and endoplasmic reticulum stress research. This scenario-driven guide connects product specifications with practical preparation, interpretation, and vendor-selection decisions.

16405 records 1/1094 page Next 12345 下5页 Last page